PTC Therapeutics Q2 2019 Earnings Report

Total Revenue
$85.5M
Previous year: $68.7M
+24.4%
EPS
-$0.75
Previous year: -$0.21
+257.1%
R&D Expenses
$60M
SG&A Expenses
$49.2M
Cash, cash equivalents
$687M

PTC Therapeutics

PTC Therapeutics

PTC Therapeutics Revenue by Segment